TM6SF2 deficiency mimics the NAFLD phenotype, while liver-specific TM6SF2 OE elevates plasma TC and LDL-C levels [197]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.